CLINICAL_TRIALS
trial_result
· 2014-10-09
Clinical Trial Update: Early Prophylaxis Immunologic Challenge (EPIC) Study [Phase 3]
Summary
Phase 3 EPIC study in Hemophilia A was terminated; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 3 | Status: TERMINATED | Results posted: 2014-10-09